PortfoliosLab logoPortfoliosLab logo
CLPT vs. DLO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLPT vs. DLO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ClearPoint Neuro, Inc. (CLPT) and DLocal Limited (DLO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLPT achieves a 31.43% return, which is significantly higher than DLO's -11.69% return.


CLPT

1D
-2.97%
1M
57.17%
YTD
31.43%
6M
24.09%
1Y
54.60%
3Y*
39.95%
5Y*
-2.37%
10Y*

DLO

1D
1.07%
1M
3.54%
YTD
-11.69%
6M
-11.76%
1Y
11.89%
3Y*
2.56%
5Y*
-22.81%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLPT vs. DLO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CLPT
ClearPoint Neuro, Inc.
31.43%-11.05%126.51%-19.83%-24.51%-37.74%
DLO
DLocal Limited
-11.69%31.72%-36.35%13.62%-56.37%15.13%

Correlation

The correlation between CLPT and DLO is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.33

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (5Y)
Calculated over the trailing 5-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2021

0.34

Fundamentals

Market Cap

CLPT:

$531.25M

DLO:

$3.68B

EPS

CLPT:

-$1.01

DLO:

$0.64

PS Ratio

CLPT:

12.68

DLO:

3.05

PB Ratio

CLPT:

28.20

DLO:

6.66

Total Revenue (TTM)

CLPT:

$40.61M

DLO:

$1.21B

Gross Profit (TTM)

CLPT:

$25.32M

DLO:

$436.56M

EBITDA (TTM)

CLPT:

-$25.05M

DLO:

$280.42M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLPT vs. DLO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLPT
CLPT Risk / Return Rank: 6464
Overall Rank
CLPT Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
CLPT Sortino Ratio Rank: 7070
Sortino Ratio Rank
CLPT Omega Ratio Rank: 6969
Omega Ratio Rank
CLPT Calmar Ratio Rank: 6060
Calmar Ratio Rank
CLPT Martin Ratio Rank: 5656
Martin Ratio Rank

DLO
DLO Risk / Return Rank: 5252
Overall Rank
DLO Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
DLO Sortino Ratio Rank: 5151
Sortino Ratio Rank
DLO Omega Ratio Rank: 5050
Omega Ratio Rank
DLO Calmar Ratio Rank: 5353
Calmar Ratio Rank
DLO Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLPT vs. DLO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ClearPoint Neuro, Inc. (CLPT) and DLocal Limited (DLO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLPTDLODifference
Sharpe ratioReturn per unit of total volatility

+0.31

Sortino ratioReturn per unit of downside risk

+0.85

Omega ratioGain probability vs. loss probability

1.20

1.10

+0.11

Calmar ratioReturn relative to maximum drawdown

0.78

0.39

+0.38

Martin ratioReturn relative to average drawdown

1.20

0.78

+0.41

CLPT vs. DLO - Sharpe Ratio Comparison

The current CLPT Sharpe Ratio is 0.53, which is higher than the DLO Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of CLPT and DLO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLPT vs. DLO - Drawdown Comparison

The maximum CLPT drawdown since its inception was -84.62%, smaller than the maximum DLO drawdown of -89.99%. Use the drawdown chart below to compare losses from any high point for CLPT and DLO.


Loading charts...

Drawdown Indicators


CLPTDLODifference

Max Drawdown

Largest peak-to-trough decline

-84.62%

-89.99%

+5.37%

Max Drawdown (1Y)

Largest decline over 1 year

-70.74%

-30.45%

-40.29%

Max Drawdown (3Y)

Largest decline over 3 years

-70.74%

-68.59%

-2.15%

Max Drawdown (5Y)

Largest decline over 5 years

-79.96%

-89.99%

+10.03%

Current Drawdown

Current decline from peak

-39.26%

-81.02%

+41.76%

Average Drawdown

Average peak-to-trough decline

-53.48%

-70.23%

+16.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

45.76%

15.20%

+30.56%

Volatility

CLPT vs. DLO - Volatility Comparison

ClearPoint Neuro, Inc. (CLPT) has a higher volatility of 30.44% compared to DLocal Limited (DLO) at 11.83%. This indicates that CLPT's price experiences larger fluctuations and is considered to be riskier than DLO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLPTDLODifference

Volatility (1M)

Calculated over the trailing 1-month period

30.44%

11.83%

+18.61%

Volatility (6M)

Calculated over the trailing 6-month period

66.14%

33.70%

+32.44%

Volatility (1Y)

Calculated over the trailing 1-year period

104.43%

55.18%

+49.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

78.88%

73.46%

+5.42%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.80%

73.55%

+7.25%

Dividends

CLPT vs. DLO - Dividend Comparison

CLPT has not paid dividends to shareholders, while DLO's dividend yield for the trailing twelve months is around 1.58%.


PositionTTM2025
CLPT
ClearPoint Neuro, Inc.
0.00%0.00%
DLO
DLocal Limited
1.58%3.71%

Financials

CLPT vs. DLO - Financials Comparison

This section allows you to compare key financial metrics between ClearPoint Neuro, Inc. and DLocal Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00M20222023202420252026
12.13M
335.86M
(CLPT) Total Revenue
(DLO) Total Revenue
Values in USD except per share items

CLPT vs. DLO - Profitability Comparison

The chart below illustrates the profitability comparison between ClearPoint Neuro, Inc. and DLocal Limited over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
64.0%
35.3%
Portfolio components
CLPT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ClearPoint Neuro, Inc. reported a gross profit of 7.76M and revenue of 12.13M. Therefore, the gross margin over that period was 64.0%.

DLO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DLocal Limited reported a gross profit of 118.68M and revenue of 335.86M. Therefore, the gross margin over that period was 35.3%.

CLPT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ClearPoint Neuro, Inc. reported an operating income of -8.48M and revenue of 12.13M, resulting in an operating margin of -69.9%.

DLO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DLocal Limited reported an operating income of 53.55M and revenue of 335.86M, resulting in an operating margin of 15.9%.

CLPT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ClearPoint Neuro, Inc. reported a net income of -9.55M and revenue of 12.13M, resulting in a net margin of -78.8%.

DLO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DLocal Limited reported a net income of 41.98M and revenue of 335.86M, resulting in a net margin of 12.5%.


Frequently Asked Questions


CLPT and DLO have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLPT has higher volatility (30.44%) compared to DLO (11.83%). In terms of maximum drawdown, CLPT dropped -84.62% vs DLO's -89.99%.

CLPT currently has the higher Sharpe Ratio (0.53 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLPT and DLO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer